Kaiho-Sakuma M, Toyoshima M, Watanabe M, Toki A, Kameda S, Minato T, Niikura H, Yaegashi N. Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report.
Gynecol Oncol Rep 2018;
23:20-3. [PMID:
29326972 DOI:
10.1016/j.gore.2018.01.002]
[Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/29/2017] [Revised: 01/01/2018] [Accepted: 01/03/2018] [Indexed: 01/17/2023] Open
Abstract
Neuroendocrine tumors (NETs) frequently occur in the lungs or the gastrointestinal tract; they are uncommon in the ovary.
The mammalian target of rapamycin (mTOR) pathway has been reported as a treatment for advanced NETs.
We describe a patient with an aggressive primary ovarian NET, successfully treated with everolimus (an mTOR inhibitor).
Collapse